A downtrend has been apparent in Tarsus Pharmaceuticals, Inc. (TARS) lately with too much selling pressure. The stock has ...

Harbor Capital Advisors Inc. increased its stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 22.1% in the fourth quarter, according to its most recent 13F filing with the ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ...

Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) hit a new 52-week high on Monday . The company traded as high as $57.14 and last traded at $56.17, with a volume of 228758 shares ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...